baber/WOPTO huggingface dataset:
Patent CA-1335168-C (CA)
Inventor: KATIC MILOS
IPC: A24F19/14
Filed: 1989-04-12
Granted: 1995-04-11
Abstract: A scented extinguishing powder for ashtrays and the like is disclosed.  The powder is produced by heating volcanic-origin tuff at a temperature of 600 degrees Celsius, and then suddenly cooling in water.  Then it is completely dried and ground into 1mm granules, sieved and soaked in diluted alcohol.  The powder is then placed in an autoclave at a temperature of up to 200 degrees Celsius and at a pressure of 10 Bars for a period of approximately two hours.  After the powder is completely dried, it is poured into a tube which contains a spiral transporter whose function is to mix, by a small number of rotations, the dry powder; simultaneously, from an ultrasonic device which converts floral oil into cold vapour, the fragrance vapour is released into the tube but so that the pores of the dry granules absorb the vapour only on the surface which the spiral exposes.
Patent CA-1335071-C (CA)
Inventor: NISHIKAWA ATSUSHI
IPC: C12Q1/48
Filed: 1989-04-19
Granted: 1995-04-04
Abstract: This invention relates to a method of diagnosing can-cerous diseases, which comprises measuring the amount of UDP-N-acetylglucosamine:glycoprotein N-acetylglucosaminyl-transferase in body fluid and evaluating the increase in its amount for the diagnosis of hepatic diseases.    AFP, CEA and ?-glutamyltranspeptidase have hitherto been used as tumor markers for the diagnosis of hepatic cancer.   But these conventional tumor markers show a pos-itivity rate of about 60 %, making early diagnosis almost impossible.     The method of this invention employs UDP-N-acetyl-glucosamine:glycoprotein N-acetylglucosaminyltransferase as tumor marker, whereby early diagnosis of hepatic cancer can be made almost completely.
Patent CA-1297875-C (CA)
Inventor: ALGIERI ALDO A
IPC: A61K31/496
Filed: 1989-05-12
Granted: 1992-03-24
Abstract: Abstract of the Disclosure Histamine H2-receptor antagonists of the formula     I   wherein A, m, Z, n and R1 are as defined herein, and their nontoxic pharmaceutically acceptable salts are novel anti-ulcer agents which are prepared by ring closure of a substituted ethanediimidamide of the formula                 II
Patent CA-1326595-C (CA)
Inventor: SAKAMOTO HIDESATO
IPC: F27B9/06
Filed: 1989-05-30
Granted: 1994-02-01
Abstract: ABSTRACT OF THE DISCLOSURE    Disclosed is a furnace in which the inside of the furnace enclosed by a furnace wall having an inner surface lined with a heat insulating material.  Heaters for heating the inside of the upper furnace chamber to a predetermined temperature, and an upper turntable supported so as to be rotatable horizontally and arranged to mount works on an upper surface thereof are provided in the upper furnace chamber.  Other heaters for heating the inside of the lower furnace chamber to a predetermined tempera-ture, and a lower turntable supported so as to be rotatable hori-zontally independently of the upper turntable and arranged to mount works on an upper surface thereof are provided in the lower furnace chamber.  Delivery of a work from/to the outside of the furnace to/from each of the upper and lower turntables is per-formed by insertion of a fork through an opening formed in a predetermined position of the furnace wall.  In this configura-tion, for example, carburizing treatment on a work is carried out in the upper furnace chamber and diffusion treatment on a work is carried out in the lower furnace chamber.
Patent CA-1307358-C (CA)
Title: Ohmic electrode
Inventor: TSUCHIMOTO JUNICHI
IPC: H01L21/28
Filed: 1989-06-12
Granted: 1992-09-08
Abstract: Abstract of the Disclosure This invention comprises a Pd layer formed on an n-type GaAs semiconductor crystals, and a Ge layer being formed on the Pd layer, characterized in that the thickness of the Pd layer is between 300 .ANG. and 1500 .ANG. and the thickness of the Ge layer is between 500 .ANG. and 1500 .ANG..   And this invention provides an ohmic electrode forming process for compound semiconductor crystals for forming an ohmic electrode on an n-type GaAs semiconductor crystals, comprising a first layer forming step for forming a palladium (pd) layer on a compound semiconductor crystal; a second layer forming step for forming a germanium layer (Ge) on the Pd layer; and a annealing step for annealing the Pd layer and the Ge layer by a rapid thermal annealing treatment.   The Pd layer is formed between 300 .ANG. and 1500 .ANG. in the first layer forming step; the Ge layer is between 500 .ANG. and 1500 .ANG. in the second layer forming step; and the Pd layer and the Ge layer are heated in the annealing step for 3 seconds to 20 seconds at a temperature of 500 °C to 650 °C by a rapid thermal annealing treatment.  As the rapid thermal annealing treatment, the flash annealing treatment is effective.
Patent CA-1309101-C (CA)
Title: Process for preparing 1-(p-tert-butylphenyl)-4- [4'-(alpha-hydroxy-diphenylmethyl)-1'-piperidinyl] butanol
Inventor: MAGNI AMBROGIO
IPC: C07D211/22
Filed: 1989-06-16
Granted: 1992-10-20
Abstract: ABSTRACT           The present invention relates to a process for preparing terfenadine which is based on the reduction of terfena-done by an alkali metal borohydride, said process being characterized in that the reaction is carried out in a two-phase system in the presence of a phase transfer catalyst.  The process of the present invention permits obtaining terfenadine in each of the two substantially pure polymorphic forms directly.
Patent CA-1290027-C (CA)
Title: Rf power amplifier protection
Inventor: SWANSON HILMER I
IPC: H04B1/04
Filed: 1989-08-23
Granted: 1991-10-01
Abstract: Abstract An RF power amplifier is operated by supplying an RF signal to the amplifier for amplification and thereby providing an output RF signal to the amplifier's output circuit which has an impedance matching output network connected in series with a load.  A detector serves to detect any reflected power in the output circuit.  The RF power amplifier is turned off when the detected RF power exceeds a reference level.  The amplifier is protected by discontinuing the supply of the RF signal to the amplifier while it is turned off and, instead, a frequency signal is supplied to the RF amplifier having a frequency that corresponds with that of any current flowing in the output circuit.
Patent CA-1290580-C (CA)
Inventor: HURUTACHI HIDEAKI
IPC: A47F3/04
Filed: 1989-10-12
Granted: 1991-10-15
Abstract: ABSTRACT    A low-temperature showcase comprises a heat insulated wall,  on the top of which an opening for putting-into or taking-out commodities is formed.   The inside of the heat insulated wall is divided into an air passage and a storage chamber  thereover by  a  dividing plate which  is installed inside  this  heat  insulated  wall  in  a  nearly  horizontal fashion.   The air passage is formed in a manner that the cross-section thereof  is  of  a U-shape,   and the  storage chamber is formed surrounded by this air passage.   At both ends  of  the  air  passage,   vent ports  are  formed at  the positions facing each other through the opening of the heat insulated wall inbetween.    The air passage is divided into two parts by a fan case corresponding to the respective vent ports  and  a  blast  fan  which  can  rotate  reversibly  is supported by this fan case.   In each halved air passage,  an evaporator is installed in the vicinity of the vent port, and when one of the evaporators is put  in cooling operation, the other evaporator is subjected to defrosting.    An electric heater  is  installed  between  each  vent  port  and  each evaporator, and these electric heaters are energized when the corresponding evaporator is to be defrosted.   By means of a thermo-switch,  energizing of the electric heater is stopped when the air temperature in the air passage rises above a predetermined value during energizing the electric heater.
Patent CA-1313245-C (CA)
Inventor: GLUCK ERIC H
IPC: A61M16/00
Filed: 1991-05-13
Granted: 1993-01-26
Abstract: ABSTRACT OF THE DISCLOSURE    Respiration therapy is accomplished by generating pulses of inhalation gas for delivery to a patient.  The inhalation gas pulses may be generated by entraining humidified low pressure gas with pulses of high pressure entrainment gas.  The pulses of entrainment gas may be of variable frequency, duration and duty cycle and are produced by modulating the flow of a highly pressured gas with a solenoid operated valve.
Patent CA-1339047-C (CA)
Title: Production of erythropoietin
Inventor: LIN FU-KUEN
IPC: C07K16/00
Filed: 1984-12-12
Granted: 1997-05-27
Abstract: Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of mammalian erythropoietin ("EPO") which are characterized in preferred forms by being the product of procaryotic or eucaryotic host expression of an exogenous DNA sequence. Illustratively, genomic DNA, cDNA and manufactured DNA sequences coding for part or all of the sequence of amino acid residues of EPO or for analogs thereof are incorporated into autonomously replicating plasmid or viral vectors employed to transform or transfect suitable procaryotic or eucaryotic host cells such as bacteria, yeast or vertebrate cells in culture.  Upon isolation from culture media or cellular lysates or fragments, products of expression of the DNA sequences display, e.g., the immunological properties and in vitro and in vivo biological activities of EPO of human or monkey species origins. Disclosed also are chemically synthesized polypeptides sharing the biochemical and immunological properties of EPO.  Also disclosed are improved methods for the detection of specific single stranded polynucleotides in a heterologous cellular or viral sample prepared from, e.g., DNA present in a plasmid or viral-borne cDNA or genomic DNA "library".
Patent DK-159323-C (DK)
Inventor: LAURENT HENRY
IPC: A61K31/565
Filed: 1985-05-14
Granted: 1991-03-25
Abstract: Estriol esters of Formula I    <IMAGE>  (I)  wherein R, in each case, means the residue of a monocarboxylic acid of 2-10 carbon atoms. The novel estriol esters surpass estriol in strength and duration of estrogen effect.
Patent DK-147979-C (DK)
Inventor: GESSNER WOLFGANG
IPC: E04D5/12
Filed: 1979-06-20
Granted: 1985-08-26
Abstract: The flame resistance of a bituminized roof sheet consisting of a reinforced fleece, a metal foil and bitumen is improved substantially by applying a metal foil to one face. A rupture of the metal foil in the case of stress due to elongation is prevented by wrinkling it. The elongation reserve thus obtained is in the range of from 2 to 35%.
Patent DK-164667-C (DK)
Inventor: BUSCHMANN ERNST
IPC: A01N43/84
Filed: 1984-06-15
Granted: 1992-12-21
Abstract: 1. Claims for the contracting states : BE, CH, DE, FR, GB, IT, LI, NL, SE A 2,6-trans-dimethylmorpholine derivative of the formula  see diagramm : EP0129211,P8,F2  where R is a Cycloalkyl, Cycloalkylalkyl or alkyl radical which can be substituted by one or more C1 -C7 -alkyl radicals, and the total number of carbon atoms in the substituent R is from 7 to 20, and its N-oxides and plant-tolerated addition salts with acids and metal complexes. 1. Claims for the contracting state : AT A fungicide containing a 2,6-trans-dimethylmorpholine derivative of the formula  see diagramm : EP0129211,P9,F1  where R is a cycloalkyl, cycloalkylalkyl or alkyl radical which can be substituted by one or more C1 -C7 -alkyl radicals, and the total number of carbon atoms in the substituent R is from 7 to 20, and its N-oxides and plant-tolerated addition salts with acids and metal complexes.
Patent DK-157688-C (DK)
Inventor: ZALISZ RENE
IPC: C12R1/22
Filed: 1981-09-18
Granted: 1990-07-09
Abstract: Novel water-soluble, immunostimulating glycoproteins extracted from Klebsiella pneumoniae containing 30 to 45% by weight of proteins, 30 to 40% by weight of neutral saccharides, up to 4% by weight of glucuronic acid, 2 to 5% by weight of osamines and having a molecular weight of about 350,000 daltons.
Patent FI-69465-C (FI)
Inventor: KJELLIN PER GUNNAR
IPC: C07D473/06
Filed: 1981-04-16
Granted: 1986-02-10
Abstract: The invention refers to compounds having activity against chronic obstructive airway disease or cardiovascular disease, characterized by the formulawherein R' is ethyl, n-propyl, n-butyl, isobutyl, n-pentyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, cyclopropyl, cyclobutyl, cyclopentyl or cyclohexylmethyl, and R<sup>2 </sup>is methyl, ethyl, n-propyl, isopropyl, cyclopropyl, n-butyl, isobutyl, tert. butyl, or cyclobutyl provided that R' is ethyl when R<sup>2</sup> is methyl, or a physiologically acceptable salt thereof. The invention also refers to processes for the preparation of these compounds, a pharmaceutical preparation containing one of the compounds and a method for the treatment of chronic obstructive airway disease and cardiovascular disease.
Patent FI-69744-C (FI)
Inventor: BECKER REINHOLD
IPC: A22C11/02
Filed: 1982-06-29
Granted: 1986-05-26
Abstract: A device for deshirring, smoothing and braking a shirred tubular casing during stuffing of the casing with a fluid mass flowing under pressure from the stuffing horn of a stuffing machine into the tubular casing. The device comprises an annular body having a central opening releasably securable to the stuffing horn, said annular body having recesses on its outer surface extending parallel to its longitudinal axis. The recesses have a substantially U-shaped, V-shaped or rectangular cross-sectional configuration or end view configuration. The configuration of the braking and smoothing elements corresponds to that of the recesses in the surface of the annular body. The braking elements and/or the annular body are displaceable relative to each other either parallel to the longitudinal axis of the stuffing horn or the elements are displaceable perpendicular to the longitudinal axis of the stuffing horn so that the braking elements can be extended into the recesses or spaced away from the recesses. An apparatus comprising a device of the aforementioned type is also disclosed.
Patent FI-72455-C (FI)
Inventor: REUTHER WOLFGANG
IPC: B27K3/50
Filed: 1982-12-01
Granted: 1987-06-08
Abstract: A wood preservative comprises a mixture of A. N-cyclohexyl-N-methoxy-2,5-dimethyl-furan-3-carboxamide and B. tris-(N-cyclohexyl-diazeniumdioxy)-aluminum. A process for treating wood with this mixture is also described.
Patent FI-76340-C (FI)
Inventor: FRECHET DANIEL
IPC: C07D487/06
Filed: 1983-10-11
Granted: 1988-10-10
Abstract: Novel 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,l-j-k][1]-benzazepin- 2-(1H)-one derivatives of the formula   <IMAGE>   wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 8 carbon atoms optionally substituted with a hydroxyl, aryl and aryloxy of 6 to 10 carbon atoms, cycloalkyl of 3 to 7 carbon atoms optionally interrupted with a heteroatom optionally substituted with alkyl of 1 to 4 carbon atoms and the wavy lines indicates that the 7-OH and 6-amino have the trans configuration and their non-toxic, pharmaceutically acceptable acid addition salts having remarkable anti-hypertensive and hypotensive activity and vasodilatatory activity and their preparation.
Patent FI-84987-C (FI)
Inventor: ANDRADA GALAN MARIO
IPC: B26D7/12
Filed: 1986-11-12
Granted: 1992-02-25
Abstract: Blade sharpening device for numerically controlled cutting machines for cutting sheet-like materials like fabrics, plastics etc., having a cutting head which moves over the surface of a cutting table by two carriages with orthogonal movements. During the sharpening process the reciprocating blade of the cutting head is raised above the cutting surface and the cut material. A motor for the drive of sharpening grinders and a numerically controlled clutch connecting the motor shaft with the grindstone shaft are mounted to the cutting head. The grinders are part of a V-shaped mount assembly - one grinder at each arm - pivotally mounted around the grindstone shaft which has a friction wheel at its top end on which the drive motor can act by a further friction wheel which is part of the clutch; see Figure 3.
Patent FI-89601-C (FI)
Inventor: PEET NORTON P
IPC: C07D487/04
Filed: 1989-09-20
Granted: 1993-10-25
Abstract: The present invention is directed to a group of compounds which are imidazol[2,1-b]quinazolin-5(3H)-ones, related tricyclic compounds, and pharmaceutically acceptable salts thereof. These compounds are useful as bronchodilators. These compounds are prepared by the reaction of an appropriate hydrazine with an appropriate 1-substituted-2-methyl-2-imidazoline or chemically equivalent compound.
Patent FI-92005-C (FI)
Inventor: GUICHARD PHILIPPE
IPC: H04N7/24
Filed: 1990-01-17
Granted: 1994-09-12
Abstract: PCT No. PCT/NL89/00037 Sec. 371 Date Mar. 20, 1990 Sec. 102(e) Date Mar. 20, 1990 PCT Filed May 19, 1989 PCT Pub. No. WO89/11767 PCT Pub. Date Nov. 30, 1989.In order to reduce the digital data throughput, the transmission system comprises means for determining, for each image, in the set of speed vectors, a subset containing the vectors which are encountered most frequently in this image, and means for digitally transmitting, once per image, the characteristics of all the vectors of this subset, and if the speed vector of an image part to be transmitted is an element of the subset, it is defined by reference to the subset, while, if it is not an element of the subset, another transmission mode is used for the current image part, being a mode in which the speed vector is not used, but in which the analog video data are transmitted with a lower spatial definition but with a higher frame rate.
Patent NO-156597-C (NO)
Inventor: LANTZ INGVAR
IPC: A63B21/008
Filed: 1984-09-06
Abstract: PCT No. PCT/SE83/00430 Sec. 371 Date Aug. 23, 1984 Sec. 102(e) Date Aug. 23, 1984 PCT Filed Dec. 6, 1983 PCT Pub. No. WO84/02659 PCT Pub. Date Jul. 19, 1984.A muscle training apparatus comprising a force arm (1) which is rotatably mounted in a carrier (2) and which cooperates with a simple acting or double acting force applying means, especially a gas spring (8) which with one end is rotatably mounted in a bracket (7) of a lever arm (4) included in the force arm, and which with the opposite end is adapted for being mounted in an optional position in the carrier (2) on different distances from the axis of rotation (5) of said lever arm. The force arm (1) is adapted to quickly and easily be rotated from traction operation to pressure operation and vice versa and in an optional position on a support (3). Two or more force arms (1) can be mounted on one and the same support (3) for combined traction or pressure actuation in many different alternative embodiments.
Patent NO-168601-C (NO)
Inventor: BAGUENA MICHEL
IPC: F02M43/00
Filed: 1987-03-12
Abstract: An injector apparatus for an internal combustion engine and suitable for injecting two different fuels, namely a "pilot injection" liquid fuel and a "main injection" liquid or gaseous fuel comprising a low-pressure pump (1B) for pilot injection fuel feed, a high-pressure pump (1A) of the injection pump type, two fuel injectors, and a metering pump (30) selectively connecting the low-pressure pump, the high-pressure pump, and the two fuel injectors. The metering pump (30) includes a transfer piston (2) and two abutments (3, 4) which are independently adjustable so as to vary the relative importance of pilot injection and of main injection and also vary the extent to which the two injection stages overlap.
Patent NO-174987-C (NO)
Inventor: OAKES MARTIN CHRISTOPHER
IPC: H02B13/02
Filed: 1988-03-11
Abstract: A three-phase electrical ring main unit comprising a lower chamber module (30) having a wall structure formed from insulating resin material; three input contacts (35), one for each phase, mounted within the lower chamber; three lower switching contacts (37), each mounted within the lower chamber for movement between different switching positions; insulating closure means (55) closing the top of the lower chamber; three output contacts (49), one for each phase, carried by and exposed on a lower face of the closure means; three busbar contacts (59 to 61), each electrically connected to a respective output contact, carried by and exposed on an upper face of the closure member (55); an upper chamber module (31) having a wall structure formed from insulating resin material; means (32) securing the upper chamber above the lower chamber; three tee-off contacts (85), one for each phase, mounted within the upper chamber; and three upper switching contacts (83), each mounted in the upper chamber for movement between different switching positions; one switching position of the lower switching contacts effecting electrical connection between the input contacts and their associated output contacts; and one switching position of the upper switching contacts effecting electrical connection between the busbar contacts and their respective tee-off contacts.
Patent NO-176814-C (NO)
Inventor: LONG ROBERT T
IPC: E04B1/41
Filed: 1988-12-30
Abstract: A plastic shear connector (16) for forming an insulated wall having an improved fiber composite or plastic shear connector which is used to form a composite wall formed of an insulating sheet (14) and one or more concrete layers (13) wherein the shear connectors (16) are formed with tapered ends (25, 30) and have a holding portion injection molded and mounted on the center portion (17) of the shear connector (16) and which is inserted through the insulating board (14) as the composite wall is formed.
Patent NO-175260-C (NO)
Inventor: LINNAU YENDRA
IPC: C12S3/14
Filed: 1989-07-27
Abstract: For the production of Lys-plasminogen, with a specific activity of at least 17.5 caseinolytic units/mg of protein and at least 50  mu mol/g protein nitrogen, and an electrophoretic purity of at least 90%, entailing plasminogen being adsorbed from plasma, from a plasminogen-containing fraction or from a tissue culture for the purpose of purification on immobilised lysine, eluted and obtained from the eluate with a protein precipitant, a solution of the plasminogen purified in this way is adjusted to a plasmin activity which is, for the chromogenic substrate H-D-Valyl-L-Leucyl-L-lysine p-nitroanilide dihydrochloride, in the range from 0.005 to 0.2  mu mol/ml.min, preferably 0.01 to 0.1  mu mol/ml.min, is maintained at a temperature of +1 DEG C to +20 DEG C, preferably +4 DEG C to +12 DEG C, for a period of 6 to 60 hours, preferably 15 to 50 hours, in order to achieve enzymatic proteolytic conversion of the plasminogen into Lys-plasminogen, after which the enzyme reaction is stopped and Lys-plasminogen is isolated.
Patent NO-177409-C (NO)
Inventor: THEVENET GUY
IPC: H05K5/06
Filed: 1990-05-11
Abstract: Impervious envelope based on a filamentary winding consisting of glass fibres impregnated with resin, for equipment likely to undergo substantial thermal stresses and to be the site of internal overpressures, the said winding adhering to the outer surface of the said equipment, characterised in that the said outer surface of the said equipment covered with the said winding offers zones not covered by fibres and forming resin-filled pockets, the percentage of surface area not covered by fibres being of the order of at least 15%. 
<IMAGE>
Patent NO-177766-C (NO)
Inventor: ENTERRIA JOSE JAVIER GONZALES
IPC: F03B7/00
Filed: 1990-11-05
Abstract: This machine consists of an impeller formed by a right prism with a minimum weight/volume ratio and which has an irregular hexagonal section, three sides of which are bigger than the other three, and with said hexagon's vertexes belonging to a single circumference. The second body of said machine is formed by an open cylindrical chamber, concentric to the impeller, with an angle of approximately 83 degrees. Its basic characteristic is its high performance in obtaining energy produced by minimum height waterfalls.